Prevention and control of noncommunicable diseases in Kyrgyzstan. The case for investment (2017)
This report provides evidence through three analyses - economic burden, intervenion cost, and cost-benefit - in Kyrgyzstan that NCDs reduce economic output and discusses potential options in response, outlining details of their relative returns on investment.
Sign Up to start bookmarking content
World Economic Forum
World Health Organization